swing back between hope and frustration
I swing back and forth on TLT so much. Some things give me hope and other things give me frustration.
Hopeful attributes
- great science by someone not directly employed by the company. Dr. MacFarland's work is amazing and separate so we are not just trusting some possibly misrepresented science from the company itself. Companies have been known to fudge science.
- phase 1b results where 2/3 worst of the worst cancer patients were cured for good of their repeatedly recurring multifocal bladder cancer in one treatment. Followed for years of follow up and no recurrence. (That is what got me into TLT in the first place.)
- study is lead by someone not employed by TLT. All the study sites are also independent. Gives a bit of insulation from our well-founded concerns around competence by company management.
- CR numbers beat most competitors.
- most competitors have products that required many many instillations AND/OR IV therapy with side effects.
- Med Adv Board is Dr. Kamat, one of the leading names in Bladder Cancer and co-author on most of the recent posters presented.
- TLT has done a phase 2 trial, so far, on quite a low budget compared to what most spend.
- TLT appears to be debt free.
- The insiders who know the most have always bought in when they can and have not sold a single share in years (if ever). This includes RDW and Dr. Mandel, the lead scientist.
- they have the potential for IV version of their drug.
- they have rights to a whole category of similar drugs that may work even better (for example, the uber-drug published a while ago)
- low market cap and low share when I personally have bought shares. My own average is around 0.28. Not many promising biotech companies for which can buy in a such a low market cap.
- the recent hire for the BOD who is medical, Boston based, American which is a nice addtion.
Frustration and resentment from:
- RDW's strange history of misrepresenting information and getting in trouble for it.
- Vera's in and out hiring mess
- Shawn's abrupt departure
- Trikola's strange hiring and firing.
- RDW's history of pointless litigation against internet trolls.
- the constant prediction of imminent BTD and then the timeline being shifted again
- the clumsy use of small hand to mouth PPs to get cash infusions (small cash each time, but enough to drop price back down to 0.235 when they are building).
- the inability to get cash from a variety of sources such as licensing agreements, JV partnerships etc. anything other then all these PP's.
All in all, I'm fine to keep longholding (like I have a choice) as I believe in the very unique science but not without feelings of frustration towards the management. Mainly for the clumsy use of PP's that are so small that they lead to another PP, months after the last one. If there is in fact another PP happening as per a previous poster. It will take some strong statements to convince people that they are done PP's at some point. If we all expect a new PP every few months, no one is going to bid up the price.
I feel that RDW consider this his baby and legacy. And that may be one reason he has not gotten outside money before now. Trying to do it on his own.
The only good thing about the PP (if there is one) is that any holders with some new cash can always buy a bit more at 0.235 to 0.25 if they are not on the invited list for the PP. That is a nice price to buy the dip even if it is so frustrating for the rest of us who are maxed our and holding.
All IMO